AstraZeneca chief links Europe’s Covid surge to rejection of firm’s vaccine
A decision not to use AstraZeneca’s Covid-19 vaccine for elderly people in some European countries could help explain why the virus is currently triggering such high levels of infections in mainland Europe, the company’s chief executive has said.
Pascal Soriot told BBC Radio 4’s Today programme that heightened T-cell immunity could be giving those who received the Oxford/AstraZeneca jab more durable immune protection against the virus.
His comments came as the former chair of the UK vaccine taskforce Dame Kate Bingham urged the government to do better in its preparation for future disease outbreaks. Writing in the Times, she said that the machinery of Whitehall was “dominated by process, rather than outcome, causing delay and inertia”, adding
Read more on theguardian.com
